Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Analysis & Investment Frameworks
Telomir Pharmaceuticals, Inc. Common Stock (TELO) stock analysis on Invetso. Review Telomir Pharmaceuticals, Inc. Common Stock’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Telomir Pharmaceuticals, Inc. Common Stock Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Telomir Pharmaceuticals, Inc. Common Stock Key Financial Metrics
- Market Cap: $75.09M
- Revenue: $N/A
- ROE: -102.69%
- ROIC: -120.93%
- Dividend Yield: N/A
About Telomir Pharmaceuticals, Inc. Common Stock
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.
Telomir Pharmaceuticals, Inc. Common Stock Investment Frameworks
Invetso analyzes Telomir Pharmaceuticals, Inc. Common Stock (TELO) across the following frameworks:
- Telomir Pharmaceuticals, Inc. Common Stock 10Y Growth Potential
- Telomir Pharmaceuticals, Inc. Common Stock Scenario Analysis
- Telomir Pharmaceuticals, Inc. Common Stock Risks & Opportunities
- Telomir Pharmaceuticals, Inc. Common Stock Economic Moat
- Telomir Pharmaceuticals, Inc. Common Stock Business Model
- Telomir Pharmaceuticals, Inc. Common Stock Management
- Telomir Pharmaceuticals, Inc. Common Stock SWOT Analysis
- Telomir Pharmaceuticals, Inc. Common Stock Porter's 5 Forces
- Telomir Pharmaceuticals, Inc. Common Stock PESTLE Analysis
- Telomir Pharmaceuticals, Inc. Common Stock ESG Analysis